Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002044
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Pilot Study To Evaluate the Effect of Retrovir Zidovudine AZT in the Treatment of Human Immunodeficiency Virus HIV Associated Dementia and Neuromuscular Diseases
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Pilot Study To Evaluate the Effect of Retrovir Zidovudine AZT in the Treatment of Human Immunodeficiency Virus HIV Associated Dementia and Neuromuscular Diseases
Status:
COMPLETED
Status Verified Date:
1995-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this pilot study is to evaluate the efficacy of Retrovir AZT in the treatment of AIDS-related dementia and various neuromuscular complications HIV is both a lymphotropic and neurotropic virus which can affect both the central and peripheral nervous systems CNS PNS There is evidence that the CNS and PNS may harbor the virus in a latent state with the potential for continuous reinfection of other body systems Therefore effective therapeutic efforts against HIV infection should provide effective antiviral activity within the nervous system
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 14 | None | None | None |